going once going twice, page-43

Maybe the fact that management does not appear to give a Fig
in regards to EU sales is not a fact but rather an assumption.

Maybe the real fact is that it is difficult and slow and likely
highly costly too to penetrate or create (a VCR) market there
-remember medical bureaucracy etc.

I find hard to believe that if it was easy money/sales mngmt would ignore
and disregard that market in favour of any other that is way away atm
and besides they are trying other markets i.e India? etc...
so it looks like they are trying wherever they can-give them credit for that-
so this notion should be taken into account and examined in a new light.


(I think also that before AGM mangnt may buy some nominal stock
if not to have to wear protective helmets on the day, lol!)